Design and Evaluation of Tramadol HCl Sustained Release Matrix Tablets

T Archana,Raju Kundavaram,M Gayathri Devi

DOI: https://doi.org/10.26463/rjps.6_4_1

2016-01-01

Rajiv Gandhi University of Health Sciences Journal of Pharmaceutical Sciences

Abstract:The objective of present study was to designand evaluate Tramadol HCl sustained release matrix tablets. Tramadol is an opioid agonist commonly prescribed for the treatment of acute or chronic pain. Tramadol has a moderate half-life of six hours. Patients have to take multiple doses throughout the day to maintain the effect which results in dependence and addiction. So an attempt is made to develop a sustained release matrix tablets to achieve therapeutically effective concentrations of drug in systemic circulation over an extended period of time thereby the dosing frequency can be reduced. Formulation contains tramadol hydrochloride MCC HPMC K100M xanthan gum PVP K-30 isopropyl alcohol magnesium stearate and talc. Various formulations were developed using different concentrations of rate releasing polymer Xanthan gum and HPMC K100M for extending the drug release up to 10 h. The study involved preparation of granules by wet granulation technique followed by pre compression evaluation and tablet punching using a compression machine followed by post compression evaluation and only the one which met standards was selected and analyzed for drug content using UV- Visible spectrophotometer. From the results it was found that as the polymer concentration was increased the rate of drug release was retarded.